中的GABAA受体:通过对遗传变异的功能分析来阐明表型差异
Nathan L Absalom1,2, Susan X N Lin2, Vivian W Y Liao2
1School of Science, University of Western Sydney, Sydney, New South Wales, Australia.
Journal of neurochemistry
|August 25, 2023
概括
γ-氨基黄油酸A型 (GABAA) 受体中的遗传变异与有关. 了解这些变异如何影响受体功能是开发个性化治疗的关键.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 正常的大脑功能依赖于刺激性和抑制性神经传递的平衡.
- γ-氨基黄油酸A型 (GABAA) 受体是哺乳动物大脑中主要的抑制性离子通道.
- 对GABAA受体的调节失调与有关,许多亚单元变异与这种疾病有关.
研究的目的:
- 审查关于遗传GABAA受体变体和的当前知识.
- 突出了解个性化疗法的变异特异性功能变化的重要性.
- 为未来的功能分析提供与临床指南一致的建议.
主要方法:
- 关于与相关的遗传变异的文献综述.
- 分析遗传变异如何影响GABAA受体功能 (功能增加,功能丧失).
- 讨论功能变异分类的方法.
主要成果:
- 数百种GABAA受体子单元变异与遗传相关的有关.
- 变体识别本身并不能预测治疗反应.
- 功能性表征对于理解变异对受体特性影响至关重要.
结论:
- 了解GABAA受体变体的功能后果对于开发精确疗法至关重要.
- 根据临床指导方针进行变异分类,需要标准化功能测试.
- 对变异特异性影响的进一步研究将推动针对的个性化医学.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
460
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
460
Arteries of the Lower Limbs
213
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
213
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
344
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
344
Antiepileptic Drugs: Glutamate Antagonists
421
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
421
Antiepileptic Drugs: Potassium Channel Activators
211
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
211
Epistasis Analysis
5.1K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
5.1K


